Latest market price
36.28
+0.91+2.57%
OverviewShort InterestFilings
INDVQT69Indivior Pharmaceuticals Inc·NASDAQ
36.28+2.57%

Latest SEC Filings

Form category
DescriptionFilingDocument
Nov 02, 20268-KCurrent report
Oct 29, 2026425Prospectus / business-combination communication
Oct 29, 202610-QQuarterly report
Oct 29, 20268-KCurrent report
Oct 15, 20268-KCurrent report
Oct 06, 20268-KCurrent report
Oct 06, 2026425Prospectus / business-combination communication
Sep 30, 2026SC 13GBeneficial ownership statement (passive)
Sep 17, 2026425Prospectus / business-combination communication
Sep 17, 20268-KCurrent report
Sep 15, 20268-KCurrent report
Sep 11, 2026EFFECTNotice of effectiveness
Sep 11, 2026424B3Prospectus
Sep 09, 2026S-4/AS-4/A
Aug 28, 2026S-4Registration statement (M&A)
Aug 27, 20264Statement of changes in beneficial ownership
Aug 13, 2026SC 13D/ABeneficial ownership statement (active, amended)
Aug 05, 20264Statement of changes in beneficial ownership
Aug 04, 2026425Prospectus / business-combination communication
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
Aug 03, 2026425Prospectus / business-combination communication
Aug 03, 20268-KCurrent report
#1 / 25 of 529
Page
▼
/ 22